ALPS Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-65,366
| Closed | -$1.62M | – | 956 |
|
|
2018
Q3 | $1.62M | Buy |
65,366
+11,952
| +22% | +$297K | 0.01% | 278 |
|
|
2018
Q2 | $1.47M | Buy |
53,414
+5,433
| +11% | +$149K | 0.01% | 264 |
|
|
2018
Q1 | $1.48M | Buy |
47,981
+13,702
| +40% | +$422K | 0.01% | 244 |
|
|
2017
Q4 | $1.23M | Buy |
34,279
+3,928
| +13% | +$140K | 0.01% | 227 |
|
|
2017
Q3 | $836K | Buy |
30,351
+3,027
| +11% | +$83.4K | 0.01% | 270 |
|
|
2017
Q2 | $721K | Buy |
27,324
+2,793
| +11% | +$73.7K | 0.01% | 284 |
|
|
2017
Q1 | $510K | Sell |
24,531
-2,873
| -10% | -$59.7K | ﹤0.01% | 393 |
|
|
2016
Q4 | $567K | Sell |
27,404
-8,909
| -25% | -$184K | ﹤0.01% | 305 |
|
|
2016
Q3 | $589K | Sell |
36,313
-3,677
| -9% | -$59.6K | ﹤0.01% | 253 |
|
|
2016
Q2 | $544K | Buy |
39,990
+8,431
| +27% | +$115K | ﹤0.01% | 240 |
|
|
2016
Q1 | $551K | Sell |
31,559
-5,409
| -15% | -$94.4K | 0.01% | 207 |
|
|
2015
Q4 | $1.26M | Sell |
36,968
-513
| -1% | -$17.5K | 0.01% | 206 |
|
|
2015
Q3 | $11.2K | Buy |
37,481
+13,743
| +58% | +$4.09K | 0.01% | 211 |
|
|
2015
Q2 | $759K | Buy |
23,738
+11,954
| +101% | +$382K | 0.01% | 226 |
|
|
2015
Q1 | $244K | Buy |
+11,784
| New | +$244K | ﹤0.01% | 634 |
|